- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Rafael Holdings Inc Class B (RFL)
Rafael Holdings Inc Class B stock price live, this page displays NYSE RFL stock exchange data. View the RFL premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Rafael Holdings Inc Class B real time stock price chart below.
What Is the Rafael Holdings Inc Class B Stock Price Today?
The Rafael Holdings Inc Class B stock price today is 1.850.
What Is the Stock Symbol for Rafael Holdings Inc Class B?
The stock symbol for Rafael Holdings Inc Class B is "RFL."
What Stock Exchange Does Rafael Holdings Inc Class B Trade On?
Rafael Holdings Inc Class B is listed and trades on the NYSE stock exchange.
Is Rafael Holdings Inc Class B a Good Stock to Buy?
Determining whether Rafael Holdings Inc Class B—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the RFL quote. (ISIN: US75062E1064)
What Is the Rafael Holdings Inc Class B Stock Price Today?
The Rafael Holdings Inc Class B stock price today is 1.850.
What Is the Stock Symbol for Rafael Holdings Inc Class B?
The stock symbol for Rafael Holdings Inc Class B is "RFL."
What Stock Exchange Does Rafael Holdings Inc Class B Trade On?
Rafael Holdings Inc Class B is listed and trades on the NYSE stock exchange.
Is Rafael Holdings Inc Class B a Good Stock to Buy?
Determining whether Rafael Holdings Inc Class B—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the RFL quote. (ISIN: US75062E1064)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.770
1.940
52 wk Range
1.120
3.960
RFL is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.7701.940
52 wk Range
1.1203.960
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
RFL Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has taken a big hit over the last week
Form 4 Rafael Holdings Inc Class B For: 1 August- Investing.com
Form 4 Rafael Holdings Inc Class B For: 23 June- Investing.com
- Form 4 Rafael Holdings Inc Class B For: 1 August
- Investing.com
- Form 4 Rafael Holdings Inc Class B For: 23 June
- Investing.com
Form 4 Rafael Holdings Inc Class B For: 16 June- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell
Earnings
Latest Release
Jun 11, 2026
EPS / Forecast
-0,08 / --
Revenue / Forecast
179K / --
Compare RFL to Peers and Sector
Metrics to compare | RFL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipRFLPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.0x | −2.3x | −0.3x | |
PEG Ratio | −0.10 | 0.03 | 0.00 | |
Price/Book | 1.3x | 0.7x | 2.6x | |
Price / LTM Sales | 98.2x | 1.8x | 3.1x | |
Upside (Analyst Target) | - | 30.5% | 47.6% | |
Fair Value Upside | Unlock | 6.8% | 5.6% | Unlock |
Rafael Holdings, Inc. primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and medical devices in the United States and Israel. It operates in three segments, Healthcare, Infusion Technology, and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Its lead drug candidate is Trappsol Cyclo, which is in phase 3 clinical trial being evaluated for the potential treatment of Niemann-Pick Disease Type C1 ("NPC1"), a rare, fatal and progressive genetic disorder; and CPI-613 (devimistat), a stable analog of normally transient, acylated catalytic intermediates of lipoate, which is in phase II of clinical trial. The company is also involved in developing Promitil, a molecule designed for the targeted delivery of mitomycin-C in a proprietary prodrug form, completed Phase 1A and 1B clinical studies targeting patients with advanced cancers. In addition, it engages in the development of surgical and procedural devices, including orthopedic arthroscopy instrument for Carpal Tunnel syndrome. Rafael Holdings, Inc. was incorporated in 2017 and is headquartered in Newark, New Jersey.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Rafael B (RFL) Stock Price Today?
The Rafael B stock price today is 1,850 USD.
What Stock Exchange Does Rafael B Trade On?
Rafael B is listed and trades on the New York Stock Exchange.
What Is the Stock Symbol for Rafael B?
The stock symbol for Rafael B is "RFL."
What Is the Rafael B Market Cap?
As of today, Rafael B market cap is 96,200M USD.
What Is Rafael B's Earnings Per Share (TTM)?
The Rafael B EPS (TTM) is -0,668.
From a Technical Analysis Perspective, Is RFL a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Rafael B Stock Split?
Rafael B has split 0 times.
How Many Employees Does Rafael B Have?
Rafael B has 22 employees.
What is the current trading status of Rafael B (RFL)?
As of Aug 21, 2026, Rafael B (RFL) is trading at a price of 1,850 USD, with a previous close of 1,810 USD. The stock has fluctuated within a day range of 1,770 USD to 1,940 USD, while its 52-week range spans from 1,120 USD to 3,960 USD.
What Is the RFL Premarket Price?
RFL's last pre-market stock price is 1,760 USD. The pre-market share volume is 150,000, and the stock has decreased by -0,050, or -2,760%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.